2004
DOI: 10.1016/j.transproceed.2004.05.040
|View full text |Cite
|
Sign up to set email alerts
|

Protective effect of Fructose-1,6-Bisphosphate in the cold storage solution for liver preservation in rat hepatic transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2004
2004
2013
2013

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 13 publications
0
12
0
Order By: Relevance
“…A variety of ingredients such as the stable prostacyclin (PGI2) analogue OP-4183 (Goto et al, 1993), the p38 mitogen-activated protein kinase (MAPK) inhibitor FR167653 (Yoshinari et al, 2001), the NO donor sodium nitroprusside (Rodriguez et al, 1999), the platelet-activating factor (PAF) antagonist E5880 (Takada et al, 1995), calmodulin inhibitors (Anaise et al, 1990), Ca 2+ channel blockers such as nisoldipine (Takei et al, 1990;Vajdova et al, 2002), trophic factors (Ambiru et al, 2004), caspase or calpain inhibitors, S-adenosylmethionine (SAM) (Vajdova et al, 2002), insulin (Li et al, 2003), or fructose-1,6-biphosphate (FBP) (Moresco et al, 2004) were introduced into UW preservation solution, with promising results. However, none of these modifications to UW solution composition have found their way into routine clinical practice.…”
Section: Preservation Solutionsmentioning
confidence: 99%
“…A variety of ingredients such as the stable prostacyclin (PGI2) analogue OP-4183 (Goto et al, 1993), the p38 mitogen-activated protein kinase (MAPK) inhibitor FR167653 (Yoshinari et al, 2001), the NO donor sodium nitroprusside (Rodriguez et al, 1999), the platelet-activating factor (PAF) antagonist E5880 (Takada et al, 1995), calmodulin inhibitors (Anaise et al, 1990), Ca 2+ channel blockers such as nisoldipine (Takei et al, 1990;Vajdova et al, 2002), trophic factors (Ambiru et al, 2004), caspase or calpain inhibitors, S-adenosylmethionine (SAM) (Vajdova et al, 2002), insulin (Li et al, 2003), or fructose-1,6-biphosphate (FBP) (Moresco et al, 2004) were introduced into UW preservation solution, with promising results. However, none of these modifications to UW solution composition have found their way into routine clinical practice.…”
Section: Preservation Solutionsmentioning
confidence: 99%
“…Indeed, that extended time is not often used, since more than 12 hours carries high risk of injury, mainly of biliary cells (1,3) . Moreover, in a previous study, 12 hours of cold preservation were enough to demonstrate any injury (11) . In this context, defining old rats seems essential.…”
Section: Discussionmentioning
confidence: 80%
“…It seems that FBP could exert some protective effects on grafts from older donors. Moresco et al (11) had demonstrated that FBP is able to reduce COI injury when compared to UW solution in normal fed young rats. So, our results were quite similar with their.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…FBP has been used as a component of protective solutions in the transport of donor organs, such as liver (84). Other investigators have filed a patent on FBP as a therapeutic for asthma (85), and a recent in vivo study in rats demonstrated that FBP has an inhibitory role on MC degranulation and histamine release (86).…”
mentioning
confidence: 99%